Best Medical Stocks To Buy Under $20 and 10 Best Stocks to Buy and Hold For 2025. In January 2025, the US government proposed ...

Cantor Fitzgerald lowered the firm’s price target on Molina Healthcare (MOH) to $356 from $406 and keeps an Overweight rating on the shares.

Q4 2024 Earnings Call Transcript February 6, 2025 Jeffrey Geyer: Good day, and welcome to the Molina Healthcare Fourth ...

Barclays lowered the firm’s price target on Molina Healthcare (MOH) to $339 from $372 and keeps an Equal Weight rating on the shares. The ...

Molina Healthcare CEO Joe Zubretsky downplayed attempts by Republicans to gut or limit Medicaid in upcoming reconciliation ...

Molina Healthcare, Inc.’s MOH share price has dipped by 10.09%, which has investors questioning if this is right time to buy.

LaTeena Smith pleaded guilty in December to submitting fraudulent bills for psychotherapy services for Medicaid managed care ...

Medicaid and dual-eligible contracts fuel growth for the California-based insurer, but also come with upfront implementation ...

Molina Healthcare CEO Joseph Zubretsky downplayed GOP proposals to slash spending on Medicaid, which accounts for about 80% ...

Medicaid MCR is forecasted at 89.9% for 2025, with most rate increases already known. Medicare is expected to see a slightly elevated MCR above target due to utilization pressure and suboptimal recent ...

Molina Healthcare, Inc. (NYSE: MOH) (the "Company") today reported fourth quarter 2024 GAAP earnings per diluted share of $4.44 and adjusted earnings per diluted ...

Molina Healthcare reported higher-than-expected costs tied to its government-backed Medicaid plans, sending the health insurer's shares down nearly 9% in after-hours trading.